GlassScriptPhysician profile
Phong T Dargon
NPI 1679733927
$4,186.84
in general payments reported to CMS, 2019-2025
14 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $957 · 2021: $121 · 2022: $327 · 2023: $67.95 · 2024: $1,489 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,450.16 | 2024 | |
| Bard Peripheral Vascular, INC. | $1,099.75 | 2020-2025 | Crosser Iq, Fluency Endovascular Stent Graft, Ultraverse 014 |
| Cardiovascular Systems INC. | $921.69 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $156.57 | 2019 | |
| Silk Road Medical, INC. | $148.02 | 2022 | |
| Boston Scientific Corporation | $118.91 | 2021-2022 | |
| Integra Lifesciences Corporation | $96.36 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mimedx Group, INC. | $56.83 | 2025 | |
| Medtronic, INC. | $56.66 | 2022 | |
| Imperative Care, INC | $24.37 | 2025 | Symphony Catheter |
| Tactile Systems Technology INC | $16.64 | 2023 | Entre Plus, Flexitouch Plus |
| Baxter Healthcare | $14.96 | 2022 | |
| Terumo Medical Corporation | $14.15 | 2022 | |
| Lemaitre Vascular, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phong Dargon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.